Study finds that #InterferonAlpha benefits patients with #MyeloproliferativeNeoplasms by driving mutant #BloodStemCells to become shorter-lived #WhiteBloodCells, suggesting that more targeted treatments could reduce its significant #SideEffects.
#BloodCancer #BloodCancerTreatment
#BloodCancer #BloodCancerTreatment
Myeloproliferative neoplasms: How interferon affects malignant blood stem cells – BioNews Central
Study finds that interferon-alpha benefits patients with myeloproliferative neoplasms by driving mutant blood stem cells to become shorter-lived white blood cells, suggesting that more targeted treatments could reduce its significant side effects. ..
sbee.link
September 16, 2026 at 2:18 AM
Study finds that #InterferonAlpha benefits patients with #MyeloproliferativeNeoplasms by driving mutant #BloodStemCells to become shorter-lived #WhiteBloodCells, suggesting that more targeted treatments could reduce its significant #SideEffects.
#BloodCancer #BloodCancerTreatment
#BloodCancer #BloodCancerTreatment
Single-cell analysis highlights the role of CD4(+) IFN-I-related T cells in Behcet's uveitis during Interferonalpha-2a therapy
Checking your browser - reCAPTCHA
pubmed.ncbi.nlm.nih.gov
May 5, 2026 at 8:32 PM
Single-cell analysis highlights the role of CD4(+) IFN-I-related T cells in Behcet's uveitis during Interferonalpha-2a therapy